“Atypical Hemolytic Uremic Syndrome Epidemiology” has been added to DelveInsight
Overview of Atypical Hemolytic Uremic Syndrome epidemiology, pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies
Request free sample copy here- https://www.delveinsight.com/sample-request/atypical-hemolytic-uremic-syndrome-ahus-epidemiology-forecast
Important facts of Atypical Hemolytic Uremic Syndrome Epidemiology report
- aHUS affects males and females in equal numbers whereas in adulthood, females are affected more often than males, most likely because pregnancy is a triggering event. Even though, the exact overall incidence and prevalence is unknown, the incidence in the US is estimated to be 2 individuals per 1 million in the general population. In Europe, however, the disorder is estimated to affect approximately 0.11 as per 1 million individuals between the ages of 0-18. Additionally, aHUS accounts for approximately 5-10% of all cases of hemolytic uremic syndrome.
- Estimated the annual incidence of aHUS to be two cases per million in the US and the prevalence was reported to be 3.3 per million among patients below the age of 18. In France, an incidence of 0.23 cases per million was reported. Moreover, the study also reported that aHUS may affect at any age, and approximately half of this disease usually occurs before the age of 18, without sex difference. Furthermore, the study concluded that 100-200 patients were estimated to be diagnosed in Japan, although, the epidemiology of patients with aHUS had not been well clarified based on the cohort study.
- Estimated the annual incidence of aHUS to be two cases per million in the US and the prevalence was reported to be 3.3 per million among patients below the age of 18. In France, an incidence of 0.23 cases per million was reported. Moreover, the study also reported that aHUS may affect at any age, and approximately half of this disease usually occurs before the age of 18, without sex difference. Furthermore, the study concluded that 100-200 patients were estimated to be diagnosed in Japan, although, the epidemiology of patients with aHUS had not been well clarified based on the cohort study.
Atypical Hemolytic Uremic Syndrome Symptoms
The signs and symptoms of aHUS result from the formation of tiny blood clots (microthrombi) in various small blood vessels of the body. These clots reduce or prevent proper blood flow to various organs of the body, especially the kidneys. Thus, aHUS is a complex disorder and multiple factors, including certain genetic, environmental and immunologic factors, all play a role in its development.
Atypical Hemolytic Uremic Syndrome Treatment
Clinically, the three main findings of aHUS are hemolytic anemia, thrombocytopenia, and acute kidney failure. Initial diagnosis of aHUS is made by microangiopathic hemolytic anemia (Hb < 10 g/dL, negative direct Coombs test, elevated LDH, decreased haptoglobin, and the presence of schistocytes), thrombocytopenia (platelet count
Atypical Hemolytic Uremic Syndrome Epidemiology Segmentation
- Total Prevalent cases of Atypical hemolytic uremic syndrome (aHUS) in the 7MM [2018-2030]
- Gender-specific prevalent cases of Atypical hemolytic uremic syndrome (aHUS) in the 7MM [2018-2030]
- Age-specific prevalent cases of Atypical hemolytic uremic syndrome (aHUS) in the 7MM [2018-2030]
- Type-specific Prevalent cases of Atypical hemolytic uremic syndrome (aHUS) in the 7MM [2018-2030]
- Diagnosed and Treatable cases of Atypical hemolytic uremic syndrome (aHUS) in the 7MM [2018-2030]
Atypical Hemolytic Uremic Syndrome: Report Highlights
- 11-Year Forecast of Atypical Hemolytic Uremic Syndrome(aHUS) epidemiology
- 7MM Coverage
- Total Cases of Atypical Hemolytic Uremic Syndrome(aHUS)
- Total Cases of Atypical Hemolytic Uremic Syndrome(aHUS) according to segmentation
- Diagnosed cases of Atypical Hemolytic Uremic Syndrome(aHUS)
Following is the table of content of Atypical Hemolytic Uremic Syndrome
1. Key Insights
2. Executive Summary of Atypical Hemolytic Uremic Syndrome(aHUS)
3. Atypical Hemolytic Uremic Syndrome(aHUS): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Atypical Hemolytic Uremic Syndrome Epidemiology Report: Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global Atypical Hemolytic Uremic Syndrome(aHUS) market
- Quantify patient populations in the global Atypical Hemolytic Uremic Syndrome(aHUS) market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Atypical Hemolytic Uremic Syndrome(aHUS) therapeutics in each of the markets covered
- Understand the magnitude of Atypical Hemolytic Uremic Syndrome(aHUS) population by its epidemiology
- The Atypical Hemolytic Uremic Syndrome(aHUS) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Related Reports
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
